New antiviral agents (Q36525651)

14 August 2017

1 reference

title

New antiviral agents (English)

1 reference

14 August 2017

Nahed Abdel-Haq

1

1 reference

14 August 2017

Pimpanada Chearskul

series ordinal

2

1 reference

14 August 2017

Hossam Al-Tatari

series ordinal

3

1 reference

14 August 2017

Basim Asmar

series ordinal

4

1 reference

14 August 2017

1 April 2006

1 reference

Indian Journal of Pediatrics

14 August 2017

1 reference

14 August 2017

73

1 reference

14 August 2017

4

1 reference

14 August 2017

313-321

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02825826

14 August 2017

0 references

cites work

Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine; penciclovir]

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Pharmacokinetics of famciclovir in subjects with chronic hepatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxy-methylbut-1-yl)guanine (BRL 39123) in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Famciclovir for the Treatment of Acute Herpes Zoster: Effects on Acute Disease and Postherpetic Neuralgia: A Randomized, Double-Blind, Placebo-Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Safety of famciclovir in patients with herpes zoster and genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

In vitro activities of penciclovir and acyclovir against herpes simplex virus types 1 and 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Treatment of recurrent herpes simplex labialis with oral acyclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Human papillomavirus infection and genital warts: update on epidemiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Treatment of molluscum contagiosum in males with an analog of imiquimod 1% in cream: a placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02825826

Famciclovir: review of clinical efficacy and safety

21 January 2018

1 reference

12 December 2020

Herpes labialis treatment with acyclovir 5 per cent ointment.

1 reference

12 December 2020

Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group

1 reference

12 December 2020

Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream

1 reference

12 December 2020

Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day.

1 reference

12 December 2020

Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study

1 reference

12 December 2020

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients

1 reference

12 December 2020

Brivudin compared with famciclovir in the treatment of herpes zoster: effects in acute disease and chronic pain in immunocompetent patients. A randomized, double-blind, multinational study

1 reference

12 December 2020

Imiquimod for plantar and periungual warts.

1 reference

12 December 2020

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

1 reference

12 December 2020

Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group

1 reference

12 December 2020

Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex

1 reference

12 December 2020

Oral ganciclovir and pharmacokinetics of valganciclovir in liver transplant recipients

1 reference

12 December 2020

Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis

1 reference

12 December 2020

Penciclovir cream--improved topical treatment for herpes simplex infections

1 reference

12 December 2020

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

1 reference

12 December 2020

New antiherpesvirus agents. Their targets and therapeutic potential

1 reference

12 December 2020

Topical immunomodulators--progress towards treating inflammation, infection, and cancer

1 reference

12 December 2020

Topical application of penciclovir cream for the treatment of herpes simplex facialis/labialis: a randomized, double-blind, multicentre, aciclovir-controlled trial

1 reference

12 December 2020

Imiquimod: a new possibility for treatment-resistant verrucae planae

1 reference

12 December 2020

Treatment of genital warts with an immune-response modifier (imiquimod).

1 reference

12 December 2020

Inhibition of fluorouracil catabolism in cancer patients by the antiviral agent (E)-5-(2-bromovinyl)-2'-deoxyuridine

1 reference

12 December 2020

Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum

1 reference

12 December 2020

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

12 December 2020

Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel

1 reference

12 December 2020

Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study

1 reference

12 December 2020

Potent anti-viral 5-(2-bromovinyl) uracil nucleosides are inactive at inducing gene mutations in Salmonella typhimurium and V79 Chinese hamster cells and unscheduled DNA synthesis in primary rat hepatocytes.

1 reference

12 December 2020

Treatment of human papilloma virus in a 6-month-old infant with imiquimod 5% cream

1 reference

12 December 2020

The pharmacological profile of famciclovir.

1 reference

12 December 2020

Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents

1 reference

12 December 2020

Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial

1 reference

12 December 2020

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

1 reference

12 December 2020

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

1 reference

12 December 2020

Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects

1 reference

12 December 2020

n-docosanol: broad spectrum anti-viral activity against lipid-enveloped viruses

1 reference

12 December 2020

Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group

1 reference

12 December 2020

Efficacy of valganciclovir administered as preemptive therapy for cytomegalovirus disease in liver transplant recipients: impact on viral load and late-onset cytomegalovirus disease

1 reference

12 December 2020

Recurrent herpes labialis: efficacy of topical therapy with penciclovir compared with acyclovir (aciclovir).

1 reference

12 December 2020

Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial

1 reference

12 December 2020

Treatment of herpes simplex labialis

1 reference

12 December 2020

Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial

1 reference

12 December 2020

Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.

1 reference

12 December 2020

Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial

1 reference

12 December 2020

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

1 reference

12 December 2020

Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts

1 reference

12 December 2020

A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs

1 reference

12 December 2020

Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial

1 reference

12 December 2020

Imiquimod and resiquimod as novel immunomodulators

1 reference

12 December 2020

Use of isotopically chiral [4'-13C]penciclovir and 13C NMR to determine the specificity and absolute configuration of penciclovir phosphate esters formed in HSV-1 and HSV-2 infected cells and by HSV-1-encoded thymidine kinase

1 reference

12 December 2020

Antiviral therapy of varicella-zoster virus infection in immunocompromised children--a prospective randomized study of aciclovir versus brivudin

1 reference

12 December 2020

Lethal drug interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs

1 reference

12 December 2020

Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients

1 reference

12 December 2020

Pharmacokinetics of valganciclovir and ganciclovir in renal impairment

1 reference

12 December 2020

Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02825826

1 reference

14 August 2017

1 reference